Swetha Thiruvengadam, Christina Poh, Ryan Lynch, Craig Moskowitz, Michael Spinner, Martin Hutchings, Cristina GarcĂ­a Herce, Elizabeth Phillips, Aung Tun, Julie Vose, Mina Nayeri, Erika Rudnicki, Maria Delioukina, Michelle Fanale, Sujit Biswas, Hailing Lu, Carlo Visco. "First-in-human, open-label, Phase 1 study of a novel CD30-directed antibody-drug conjugate with a topoisomerase 1 inhibitor payload, PF-08046044 (35C), in patients with Relapsed/Refractory lymphomas: Updated safety, PK, preliminary efficacy and ctdna analysis from dose escalation." Blood, 2025. doi:10.1182/blood-2025-155